Aescul Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 3.00 K
- Company Age 32 Year, 9 Months
- Open Charges ₹ 5.76 M
About Aescul Pharmaceuticals
Aescul Pharmaceuticals Limited (APL) is a Public Limited Indian Non-Government Company incorporated in India on 12 May 1992 and has a history of 32 years and nine months. Its registered office is in R R Dist, Telangana.
The Company is engaged in the Chemicals Industry.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 3.00 K .
The company currently has active open charges totaling ₹5.76 M.
Company Details
- Location R R Dist, Telangana
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24239TG1992PLC014218
- Company No.
014218
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
12 May 1992
- Date of AGM
-
- Date of Balance Sheet
-
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Aescul Pharmaceuticals?
Board Members
No Directors or KMP associated with company. Upon reviewing the records, we can confirm that there are no Directors or Key Management Personnel (KMP) associated with this company at present.
Financial Performance of Aescul Pharmaceuticals.
Enhance accessibility to Aescul Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Aescul Pharmaceuticals?
Unlock access to Aescul Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹5.76 M
₹0
Charges Breakdown by Lending Institutions
- Andhra Pradesh State Financial Corporation : 0.33 Cr
- Punjab National Bank : 0.15 Cr
- M/S Punjab National Bank : 0.09 Cr
- A P S F C : 0.01 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 Dec 1995 | Punjab National Bank | ₹1.50 M | Open |
| 21 Jan 1994 | Andhra Pradesh State Financial Corporation | ₹0.93 M | Open |
| 06 Sep 1993 | M/S Punjab National Bank | ₹0.93 M | Open |
| 20 Mar 1993 | Andhra Pradesh State Financial Corporation | ₹2.35 M | Open |
| 14 Nov 1992 | A P S F C | ₹0.07 M | Open |
How Many Employees Work at Aescul Pharmaceuticals?
Unlock and access historical data on people associated with Aescul Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aescul Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aescul Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.